Artiria Medical is a Swiss medtech company developing next-generation neurovascular access devices for minimally invasive stroke treatment. The company's flagship product, SmartGUIDE, is an FDA-cleared deflectable guidewire with a micro-articulated tip that enables real-time shape manipulation during endovascular procedures, eliminating time-consuming manual tip shaping.

The device uses embedded micro-actuator technology to allow surgeons to reorient the guidewire tip in situ while navigating the dense, tortuous cerebral vasculature. This dynamic deflection capability is designed to reduce procedural time and improve access to complex neurovascular targets during the treatment of hemorrhagic and ischemic stroke. The company has also partnered with the Wyss Center to develop a biocompatible expandable system for delivering targeted electrical energy into cerebral arteries for vasospasm treatment.

Artiria targets the neuroendovascular surgery market, serving interventional neuroradiologists and stroke surgeons. The device has been used in human cases across Europe and the United States, with a randomized controlled study underway. The company is ISO 13485 certified, has secured FDA 510(k) clearance and is pursuing European market approval. Artiria is an EPFL spin-off headquartered at Campus Biotech in Geneva.